1. Home
  2. NIE vs VSTM Comparison

NIE vs VSTM Comparison

Compare NIE & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Virtus Equity & Convertible Income Fund of Beneficial Interest

NIE

Virtus Equity & Convertible Income Fund of Beneficial Interest

N/A

Current Price

$21.23

Market Cap

658.4M

Sector

Finance

ML Signal

N/A

Logo Verastem Inc.

VSTM

Verastem Inc.

N/A

Current Price

$6.40

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NIE
VSTM
Founded
2007
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
658.4M
1.1B
IPO Year
N/A
2011

Fundamental Metrics

Financial Performance
Metric
NIE
VSTM
Price
$21.23
$6.40
Analyst Decision
Strong Buy
Analyst Count
0
10
Target Price
N/A
★ $17.22
AVG Volume (30 Days)
68.1K
★ 3.0M
Earning Date
01-01-0001
11-05-2026
Dividend Yield
★ 9.04%
N/A
EPS Growth
N/A
★ 17.49
EPS
★ N/A
N/A
Revenue
N/A
★ $30,914,000.00
Revenue This Year
N/A
$248.46
Revenue Next Year
N/A
$34.25
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 209.14
52 Week Low
$22.16
$3.43
52 Week High
$27.24
$10.82

Technical Indicators

Market Signals
Indicator
NIE
VSTM
Relative Strength Index (RSI) 19.32 27.64
Support Level N/A $5.26
Resistance Level $26.93 $6.48
Average True Range (ATR) 0.50 0.60
MACD -0.18 -0.35
Stochastic Oscillator 0.95 0.93

Price Performance

Historical Comparison
NIE
VSTM

About NIE Virtus Equity & Convertible Income Fund of Beneficial Interest

Virtus AllianzGI Equity & Convertible Income Fund is a diversified, closed-end management investment company. The investment objective is to provide total return through a combination of current income, current gains and long-term capital appreciation. The fund pursues its objective by investing in a diversified portfolio of equity securities and income-producing convertible securities. Its portfolio of investments comprises different sector investments, such as aerospace and defense, banks, IT services, software, and others.

About VSTM Verastem Inc.

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

Share on Social Networks: